Skip to main content
. 2009 Jan 8;108(1):90–99. doi: 10.1093/toxsci/kfn269

TABLE 2.

Genotype Distributions and Allele Frequencies of the Subjects

Frequency
Genotype/allele Male, n (%) Female, n (%) p Value Nonsmokers, n = 43 (%) All subjects, n = 49 (%)
CYP2E1 (Val179Ile)
    Val/Val 14 (77.8) 30 (96.8) 39 (90.7) 44 (89.8)
    Val/Ile 4 (22.2) 1 (3.2) 4 (9.3) 5 (10.2)
    Ile/Ile 0 (0.0) 0 (0.0) 0.054 0 (0.0) 0 (0.0)
    Val/Ile + Ile/Ile 4 (22.2) 1 (3.2) 4 (9.3) 5 (10.2)
CYP2E1 (Phe421Phe)
    Phe/Phe (C/C) 11 (61.1) 21 (67.7) 30 (69.8) 32 (65.3)
    Phe/Phe (T/C) 6 (33.3) 6 (19.4) 10 (23.3) 12 (24.5)
    Phe/Phe (T/T) 1 (5.6) 4 (12.9) 0.542 3 (7.0) 5 (10.2)
    Phe/Phe (C/T+T/T) 7 (38.9) 10 (32.3) 13 (30.2) 17 (34.7)
EPHX1 (Tyr113His)
    Tyr/Tyr 7 (38.9) 21(67.7) 27 (62.8) 28 (57.1)
    Tyr/His 8 (44.4) 8 (25.8) 12 (27.9) 16 (32.7)
    His/His 3 (16.7) 2 (6.5) 0.812 4 (9.3) 5 (10.2)
    Tyr/His + His/His 11 (61.1) 10 (32.3) 16 (37.2) 21 (42.9)
EPHX1 (His139Arg)
    His/His 14 (77.8) 19 (61.3) 27 (62.8) 33 (67.3)
    His/Arg 3 (16.7) 9 (29.0) 12 (27.9) 12 (24.5)
    Arg/Arg 1 (5.6) 3 (9.7) 0.790 4 (9.3) 4 (8.2)
    His/Arg + Arg/Arg 4 (22.3) 12 (38.7) 16 (37.2) 16 (32.7)
GSTP1 (Ile105Val)
    Ile/Ile 7 (38.9) 18 (58.1) 23 (53.5) 25 (51.0)
    Ile/Val 8 (44.4) 8 (25.8) 13 (30.2) 16 (32.7)
    Val/Val 3 (16.7) 5 (16.1) 0.375 7 (16.3) 8 (16.3)
    Ile/Val + Val/Val 11 (61.1) 13 (41.9) 20 (46.5) 24 (49.0)
GSTM1
    Positive 13 (72.2) 27 (87.1) 37 (86.0) 40 (81.6)
    Null 5 (27.8) 4 (12.9) 0.259 6 (14.0) 9 (18.4)
GSTT1
    Positive 11 (61.1) 13 (41.9) 23 (53.5) 24 (49.0)
    Null 7 (38.9) 18 (58.1) 0.244 20 (46.5) 25 (51.0)

Note. There are no significant differences in genotype frequencies between genders, and also no significant differences in genotype distributions between the nonsmokers subjects and all subjects.